Protoporphyrin IX in Photodynamic Assays: Protocols & Innova
2026-07-24
Unlock the full potential of Protoporphyrin IX as a photodynamic compound with advanced workflows for heme biosynthesis, ferroptosis modeling, and cancer diagnostics. This guide combines state-of-the-art research with hands-on troubleshooting, drawing on APExBIO’s high-purity reagent to maximize reproducibility and translational relevance.
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-07-23
Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), substantially enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. This study provides new mechanistic insight into how RAS-derived fragments may influence viral entry, suggesting important implications for both cardiovascular and infectious disease research.
Organic Cation Transporter Response to Xenobiotics in Mosqui
2026-07-23
Kennel and Rouhier's 2025 study investigates how Aedes aegypti mosquitoes process synthetic dyes, including Olsalazine Sodium, focusing on the role and expression of putative organic cation transporters. Their findings reveal that molecular structure of xenobiotics, rather than transporter gene expression, determines excretion patterns and mosquito mortality, providing new molecular perspectives for vector control.
Oteseconazole (VT-1161): Data-Driven Solutions for Candida A
2026-07-22
This article provides evidence-based insights for deploying Oteseconazole (VT-1161) (SKU BA1665) in cell viability and antifungal susceptibility assays. Addressing real laboratory scenarios, it guides researchers on optimizing protocols, interpreting data, and selecting reliable vendors, highlighting the reproducibility and selectivity of Oteseconazole for Candida research workflows.
Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S
2026-07-22
Moxidectin, long trusted for parasitic worm control, is now redefining antifungal strategies by synergizing with polyene drugs against Candida albicans. This article delivers a stepwise workflow, protocol tips, and troubleshooting guidance to leverage APExBIO’s high-purity moxidectin for both traditional veterinary and emerging translational research needs.
Chemically Modified SOD2 mRNA-LNPs Mitigate Renal Ischemia-R
2026-07-21
This study demonstrates that lipid nanoparticle (LNP)-delivered, chemically modified SOD2 mRNA can significantly reduce oxidative stress and renal damage following ischemia-reperfusion injury in mice. The research highlights a promising mRNA-based approach for acute kidney injury, with implications for enhancing targeted organ protection using advanced mRNA delivery technologies.
URB597 (KDS-4103): Innovating FAAH Inhibition in Translation
2026-07-21
This thought-leadership article examines URB597 (KDS-4103) as a transformative tool for translational researchers interrogating the endocannabinoid system, particularly in neuroinflammation and orofacial pain models. Blending mechanistic insights with strategic guidance, we contextualize APExBIO's URB597 within the evolving landscape of neuroplasticity and pain research, drawing from the latest evidence on endocannabinoid signaling modulation and translational pain models.
Sodium dicloxacillin monohydrate: Mechanism, Evidence, Proto
2026-07-20
Sodium dicloxacillin monohydrate is a penicillin-class β-lactam antibiotic with proven efficacy against methicillin-sensitive Staphylococcus aureus (MSSA). It operates via inhibition of bacterial penicillin-binding proteins, with well-defined in vitro and in vivo parameters. Its stability, targeted spectrum, and research-grade formulation make it a reliable choice for Gram-positive bacterial infection research.
Standardized Whole-Blood Immune Assays with Metabolic Modula
2026-07-20
The referenced study introduces a reproducible protocol for analyzing immune responses by combining whole-blood stimulation with targeted metabolic modulation. This approach advances immunometabolism research by enabling detailed assessment of cytokine production in response to metabolic inhibitors, with important implications for experimental design and therapeutic discovery.
Sodium Salicylate: NF-κB Inhibition and Translational Tumor
2026-07-19
Discover how sodium salicylate, a potent NF-κB inhibitor, empowers translational researchers to overcome tumor microenvironment barriers and accelerate inflammation and immunology breakthroughs. This thought-leadership article synthesizes mechanistic insights, experimental protocols, and strategic guidance, building on recent nanomedicine advances in pancreatic cancer stroma reprogramming.
NHS-Biotin in Protein Biotinylation: Workflow, Innovation, a
2026-07-18
NHS-Biotin (N-hydroxysuccinimido biotin) stands out for rapid, stable protein biotinylation, facilitating high-yield detection and purification. Recent advances in peptidisc-assisted nanobody clustering and optimized protocols unlock new frontiers for robust, minimally invasive labeling in both classical and next-generation biochemical research.
SB 202190: Applied Use-Cases for p38 MAP Kinase Inhibition
2026-07-17
SB 202190 empowers researchers to precisely dissect p38 MAP kinase signaling in neuroinflammation, apoptosis, and cancer models. This article delivers actionable workflows, highlights advanced applications, and provides troubleshooting strategies rooted in recent bench research.
Tiamulin (Thiamutilin): Molecular Precision in Antibacterial
2026-07-17
Discover how Tiamulin (Thiamutilin) achieves molecular selectivity as a veterinary antibiotic and anti-inflammatory agent. This article uniquely deciphers its mechanism, PK/PD optimization, and translational research frontiers, providing a deeper perspective than standard protocol guides.
Rhodamine B: Optimizing Drift Tracing & Cell Labeling Workfl
2026-07-16
Rhodamine B (Basic Violet 10) stands out as a dual-purpose, high-purity fluorescent dye for both environmental spray drift tracing and advanced cell labeling. Discover how recent UAV drift studies and reproducibility-driven protocol enhancements make it the fluorescent tracer of choice for robust, quantitative workflows.
Patient-Derived Gastric Cancer Assembloids Refine Drug Scree
2026-07-16
This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, capturing the in vivo tumor microenvironment with unprecedented fidelity. The model enables nuanced investigation of drug response variability, tumor–stroma interactions, and mechanisms of resistance, supporting more predictive preclinical and personalized therapy development.
461 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page